| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.82B | -13.7% |
| Cost of Revenue | $1.27B | -14.7% |
| Gross Profit | $549.0M | -11.2% |
| R&D Expense | $54.0M | -1.8% |
| SG&A Expense | $344.0M | -14.9% |
| Operating Income | -$775.0M | -2880.8% |
| Interest Expense | $2.0M | +0.0% |
| Pre-tax Income | -$809.0M | -3270.8% |
| Income Tax | $13.0M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $215.0M | -28.3% |
| Accounts Receivable | $242.0M | -0.4% |
| Inventory | $568.0M | +4.2% |
| Current Assets | $1.21B | +0.8% |
| Total Assets | $4.61B | -18.3% |
| Current Liabilities | $423.0M | -13.7% |
| Long-term Debt | $1.38B | +2.6% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Capital Expenditures | $98.0M | -28.5% |
| Investing Cash Flow | -$3.0M | +94.1% |
| Financing Cash Flow | -$179.0M | +62.6% |
| +105.8% |
| Net Income | -$845.0M | -600.0% |
| EPS (Basic) | -$18.23 | -636.2% |
| EPS (Diluted) | -$18.23 | -642.6% |
| Stockholders' Equity |
| $1.90B |
| -33.6% |